Advertisement

Acute Redness of the Eye

Chapter
Part of the Ocular Trauma book series (OCTRA)

Abstract

Acute redness of the eye may involve the globe, lids, or adnexal structures. It is a very common clinical sign that is often associated with eye emergencies. The three major processes responsible for the majority of red eye cases are subconjunctival hemorrhages, ocular inflammation, and vascular abnormalities. Ocular inflammation accounts for the majority of red eye presentations, whereas vascular abnormalities are the least common causes. Successful diagnosis of red eye cases requires careful differential analysis of all the possibilities, careful examinations of medical and surgical history, and complete ophthalmic examinations. Major anterior segment etiologies associated with acute red eyes are discussed in this chapter.

Keywords

Red eyes Conjunctivitis Subconjunctival hemorrhage Bacterial keratitis Corneal abrasion Corneal foreign body Dacryocystitis 

References

  1. 1.
    Roy FH. The red eye. Ann Ophthalmol. 2006;38(1):35–8.Google Scholar
  2. 2.
    Walling AD. Tips from other journals: when is red eye not just conjunctivitis? Am Fam Physician. 2002;66(12):2299–300.Google Scholar
  3. 3.
    Leibowitz HM. The red eye. N Engl J Med. 2000;343:345–51.CrossRefPubMedGoogle Scholar
  4. 4.
    Roscoe M, Landis T. How to diagnose the acute red eye with confidence. JAAPA. 2006;19(3):24–30.PubMedGoogle Scholar
  5. 5.
    Mannis MJ. Bacterial conjunctivitis. In: Tasman W, Jaeger EA, editors. Duane’s clinical ophthalmology, vol. 4. Philadelphia: JB Lippincott; 1990. p. 5.3–7.Google Scholar
  6. 6.
    Friedlander MH. Immunology of ocular infections. In: Friedlander MH, editor. Allergy and immunology of the eye. Philadelphia: Harper & Row; 1979. p. 10–20.Google Scholar
  7. 7.
    Allansmith MR. The eye and immunology. CV Mosby: St Louis; 1982. p. 75–81.Google Scholar
  8. 8.
    Buznach N, Dagan R, Greenberg D. Clinical and bacterial characteristics of acute bacterial conjunctivitis in children in the antibiotic resistance era. Ped Inf Dis J. 2005;24:823–8.CrossRefGoogle Scholar
  9. 9.
    Orden B, Martinez R, Millan R, et al. Primary meningococcal conjunctivitis. Clin Microbiol Infect. 2003;9:1245–7.CrossRefPubMedGoogle Scholar
  10. 10.
    Thygeson P, Kimura S. Chronic conjunctivitis. Trans Am Acad Ophthalmol Otolaryngol. 1963;67:494–517.PubMedGoogle Scholar
  11. 11.
    Dawson CR, Sheppard JD. Follicular conjunctivitis. In: Tasman W, Jaeger EA, editors. Duane’s clinical ophthalmology, vol. 4. Philadelphia: JB Lippincott; 1990. p. 7.2–7.220.Google Scholar
  12. 12.
    Thygeson P, Dawson CR. Trachoma and follicular conjunctivitis in children. Arch Ophthalmol. 1966;75:3–12.CrossRefPubMedGoogle Scholar
  13. 13.
    Gordon JY. The evolution of antiviral therapy for external ocular viral infections over twenty-five years. Cornea. 2000;19:673–80.CrossRefPubMedGoogle Scholar
  14. 14.
    Schmitz HR, Wigand R, Heinrich W. Worldwide epidemiology of human adenovirus infection. Am J Epidemiol. 1983;117:455–66.CrossRefPubMedGoogle Scholar
  15. 15.
    Bell JA, Rowe WP, Engler JI, et al. Pharyngoconjunctival fever. Epidemiological studies of a recently recognized disease entity. JAMA. 1955;157:1083–5.CrossRefGoogle Scholar
  16. 16.
    Dawson C, Hanna L, Wood TR, et al. Adenovirus type 8 in the United States. III. Epidemiologic, clinical and microbiologic features. Am J Ophthalmol. 1970;69:473–80.CrossRefPubMedGoogle Scholar
  17. 17.
    Dawson CR, Hanna L, Togni B. Adenovirus infections in the United States. IV. Observations on the pathogenesis of lesions in severe eye disease. Arch Ophthalmol. 1972;87:258–68.CrossRefPubMedGoogle Scholar
  18. 18.
    Dawson CR, Darrell R, Hanna L, et al. Infections due to adenovirus type 8 in the United States. II. Community-wide infection with adenovirus type 8. N Engl J Med. 1963;268:1034–7.CrossRefPubMedGoogle Scholar
  19. 19.
    Dawson CR, Darrell R. Infections due to adenovirus type 8 in the United States. I. An outbreak of epidemic keratoconjunctivitis originating in a physician’s office. N Engl J Med. 1963;268:1031–3.CrossRefPubMedGoogle Scholar
  20. 20.
    Vastine DW, West C, Yamashiroya H, et al. Simultaneous nosocomial and community outbreak of epidemic keratoconjunctivitis with types 8 and 19 adenovirus. Trans Am Acad Ophthalmol Otolaryngol. 1976;81:826–40.Google Scholar
  21. 21.
    Laibson PR, Ortolan G, Dhiri S, et al. The treatment of epidemic keratoconjunctivitis (adenovirus type 8) by corticosteroid therapy. XXI Concilium Ophthalmologicum, Mexico, Amsterdam. Excerpta Med. 1970;1246–50.Google Scholar
  22. 22.
    Hillenkamp J, Reinhard T, Ross RS, et al. Topical treatment of acute adenoviral keratoconjunctivitis with 0.2% cidofovir and 1% cyclosporin A. Arch Ophthalmol. 2001;119:1487–91.CrossRefPubMedGoogle Scholar
  23. 23.
    Hillenkamp J, Reinhard T, Ross RS, et al. The effects of cidofovir 1% with and without cyclosporin A 1% as a topical treatment of acute adenoviral keratoconjunctivitis. Ophthalmology. 2002;109:845–50.CrossRefPubMedGoogle Scholar
  24. 24.
    Chatterjee S, Quarcoopome CO, Apenteng A. An epidemic of acute conjunctivitis in Ghana. Ghana Med J. 1970;9:9–11.Google Scholar
  25. 25.
    Rheinstrom SD. The conjunctiva. In: Chandler JW, Sugar J, Edelhauser HF, editors. Textbook of ophthalmology, External diseases, vol. 8. London: Mosby; 1994. p. 2.8–9.Google Scholar
  26. 26.
    Yin-Murphy M. Viruses of acute hemorrhagic conjunctivitis. Lancet. 1973;1:545–6.CrossRefPubMedGoogle Scholar
  27. 27.
    Uchio E, Takeuchi S, Itoh N, et al. Clinical and epidemiological features of acute follicular conjunctivitis with special reference to that caused by herpes simplex virus type 1. Br J Ophthalmol. 2000;84:968–72.CrossRefPubMedPubMedCentralGoogle Scholar
  28. 28.
    Oh JO. Ocular infections of herpes simplex virus type II in adults. In: Darrell RW, editor. Viral diseases of the eye. Philadelphia: Lea & Febiger; 1985. p. 59–62.Google Scholar
  29. 29.
    Garau J, Kabins S, DeNosaquo S, et al. Spontaneous cytomegalovirus mononucleosis with conjunctivitis. Arch Intern Med. 1977;137:1631–2.CrossRefPubMedGoogle Scholar
  30. 30.
    Trott DG, Pilsworth R. Outbreaks of conjunctivitis due to Newcastle disease virus in chicken broiler factory workers. Br. J Med. 1965;3377:1514–15117.CrossRefGoogle Scholar
  31. 31.
    Polack S, Brooker S, Kuper H, et al. Mapping the global distribution of trachoma. Bull WHO. 2005;83:913–9.PubMedGoogle Scholar
  32. 32.
    Mabey DC, Solomon AW, Foster A. Trachoma. Lancet. 2003;362:223–9.CrossRefPubMedGoogle Scholar
  33. 33.
    Dawson CR, Jones BR, Tarizzo M. Guide to trachoma control. Geneva: World Health Organization; 1981. p. 56.Google Scholar
  34. 34.
    Dawson CR, Juster R, Marx R, et al. Limbal disease in trachoma and other ocular chlamydial infections: risk factors for corneal vascularization. Eye. 1989;3:204–9.CrossRefPubMedGoogle Scholar
  35. 35.
    Tabbara KF, Abu-el-Asrar A. Al-Omar O., et al: single-dose azithromycin in the treatment of trachoma: a randomized, controlled study. Ophthalmology. 1996;103:842–6.CrossRefPubMedGoogle Scholar
  36. 36.
    Bailey RL, Arullendran P, Whittle HC, Mabey DC. Randomised controlled trial of single-dose azithromycin in treatment of trachoma. Lancet. 1993;342:453–6.CrossRefPubMedGoogle Scholar
  37. 37.
    Cunningham ET, Koehler JE. Ocular bartonellosis. Am J Ophthalmol. 2000;130:340–9.CrossRefPubMedGoogle Scholar
  38. 38.
    Tullo AB, Richmond SJ, Esty PL. The presentation and incidence of paratrachoma in adults. J Hyg. 1981;87:63–9.CrossRefPubMedPubMedCentralGoogle Scholar
  39. 39.
    Katusic D, Petricek I, Mandic Z, et al. Azithromycin vs doxycycline in the treatment of inclusion conjunctivitis. Am J Ophthalmol. 2003;135:447–51.CrossRefPubMedGoogle Scholar
  40. 40.
    Chandler JW. Neonatal conjunctivitis. In: Tasman W, Jaeger EA, editors. Duane’s clinical ophthalmology, vol. 4. Philadelphia: JB Lippincott; 1995. p. 6.2–6.Google Scholar
  41. 41.
    Isenberg SJ, Apt L, Wood M. A controlled trial of povidone-iodine as prophylaxis against ophthalmia neonatorum. New Engl J Med. 1995;332:562–6.CrossRefPubMedGoogle Scholar
  42. 42.
    Nishida H, Risemberg HM. Silver nitrate ophthalmic solution and chemical conjunctivitis. Pediatrics. 1975;56:368–73.PubMedGoogle Scholar
  43. 43.
    Laga M, Plummer FA, Piot P, et al. Prophylaxis of gonococcal and chlamydial ophthalmia neonatorum: a comparison of silver nitrate and tetracycline. N Engl J Med. 1988;318:653–7.CrossRefPubMedGoogle Scholar
  44. 44.
    Harrison JR, English MG. Chlamydia trachomatis infant pneumonitis. N Engl J Med. 1978;298:702–8.CrossRefPubMedGoogle Scholar
  45. 45.
    Rapoza PA, Chandler JW. Neonatal conjunctivitis: diagnosis and treatment. Focal points 1988: clinical modules for ophthalmologists. San Francisco: American Academy of Ophthalmology; 1988. p. 5–6.Google Scholar
  46. 46.
    In: Goroll AH, Mulley AG, May LA, editors. Primary care medicine: office evaluation and management of the adult patient, 4th ed. Philadelphia: Lippincott, Williams & Wilkins; 2000. p. 742.Google Scholar
  47. 47.
    Sanders LL, Harrison HR, Washington AE. Treatment of sexually transmitted chlamydial infections. JAMA. 1986;255:1750–6.CrossRefPubMedGoogle Scholar
  48. 48.
    Prentice MJ, Hutchinson JR, Taylor-Robinson D. A microbiological study of neonatal conjunctivae and conjunctivitis. Br J Ophthalmol. 1977;61:601–7.CrossRefPubMedPubMedCentralGoogle Scholar
  49. 49.
    Burns RP, Rhodes DH Jr. Pseudomonas eye infection as a cause of death in premature infants. Arch Ophthalmol. 1961;65:517–25.CrossRefPubMedGoogle Scholar
  50. 50.
    Whitley RJ, Nahmias AJ, Visintine AM, et al. The natural history of herpes virus infection of mother and newborn. Pediatrics. 1980;66:489–94.PubMedGoogle Scholar
  51. 51.
    Chan CM, Theng JT, Li L, Tan DT. Microsporidial keratoconjunctivitis in healthy individuals: a case series. Ophthalmology. 2003;110:1420–5.CrossRefPubMedGoogle Scholar
  52. 52.
    Joseph J, Sridhar MS, Murthy S, Sharma S. Clinical and microbiological profile of microsporidial keratoconjunctivitis in southern India. Ophthalmology. 2006;113:531–7.CrossRefPubMedGoogle Scholar
  53. 53.
    De Silva DJ, Strouthidis NG, Tariq S, Davies N. An unusual cause of acute lid swelling. Eye. 2006;20:271–2.CrossRefPubMedGoogle Scholar
  54. 54.
    Fobi G, Gardon J, Santiago M, et al. Ocular findings after ivermectin treatment of patients with high Loa loa microfilaremia. Ophthalmic Epidemiol. 2000;7:27–39.CrossRefPubMedGoogle Scholar
  55. 55.
    Carithers HA. Cat scratch disease: an overview based on a study of 1200 patients. Am J Dis Child. 1985;139:1124–33.CrossRefPubMedGoogle Scholar
  56. 56.
    Jackson LA, Perkins BA, Wenger JD. Cat scratch disease in the United States: an analysis of three national databases. Am J Public Health. 1993;83:1707–11.CrossRefPubMedPubMedCentralGoogle Scholar
  57. 57.
    Spencer WH. Ophthalmic pathology: an atlas and textbook, vol. 1. 3rd ed. Philadelphia: WB Saunders; 1985. p. 176–7.Google Scholar
  58. 58.
    Rheinstrom SD. The conjunctiva. In: Chandler JW, Sugar J, Edelhauser HF, editors. Textbook of ophthalmology, Vol 8: External diseases. London: Mosby; 1994. p. 2.8–9.Google Scholar
  59. 59.
    Jones BR. Immunological specificity of follicles in conjunctivitis due to molluscum contagiosum, adenovirus and cat scratch disease. In: Nichols R, editor. Trachoma and related disorders. Princeton: Excerpta Medica; 1971. p. 243–5.Google Scholar
  60. 60.
    Ono SJ, Abelson MB. Allergic conjunctivitis: update on pathophysiology and prospects for future treatment. J Allergy Clin Immun. 2005;115:118–22.CrossRefPubMedGoogle Scholar
  61. 61.
    Bielory L. Allergic and immunologic disorders of the eye. Part II: ocular allergy. J Allergy Clin Immunol. 2006;106:1019–32.CrossRefGoogle Scholar
  62. 62.
    Stahl JL, Barney NP. Ocular allergic disease. Curr Opin Allergy Clin Immunol. 2004;4:455–9.CrossRefPubMedGoogle Scholar
  63. 63.
    Tuft SJ, Kemeny DM, Dart JK, et al. Clinical features of atopic keratoconjunctivitis. Ophthalmology. 1991;98:150–8.CrossRefPubMedGoogle Scholar
  64. 64.
    Seamone CD, Jackson WB. Immunology of the external eye. In: Tasman W, Jaeger EA, editors. Duane’s clinical ophthalmology, vol. 4. Philadelphia: JB Lippincott; 1995. p. 2.29–32.Google Scholar
  65. 65.
    Beigelman MN. Vernal conjunctivitis. Los Angeles: University of Southern California Press; 1950.Google Scholar
  66. 66.
    Stock EL, Meisler DM. Vernal conjunctivitis. In: Tasman W, Jaeger EA, editors. Duane’s clinical ophthalmology, vol. 4. Philadelphia: JB Lippincott; 1995. p. 9.1–5.Google Scholar
  67. 67.
    Foster CS, Duncan J. Randomized clinical trial of topically administered cromolyn sodium for vernal keratoconjunctivitis. Am J Ophthalmol. 1980;90:175–81.CrossRefPubMedGoogle Scholar
  68. 68.
    Secchi AG, Tognon MS, Leonardi A. Topical use of cyclosporine in the treatment of vernal keratoconjunctivitis. Am J Ophthalmol. 1990;110:641–5.CrossRefPubMedGoogle Scholar
  69. 69.
    Pleyer U, Lutz S, Jusko WJ, et al. Ocular absorption of topically applied FK506 from liposomal and oil formulation in the rabbit eye. Invest Ophthalmol Vis Sci. 1993;34:2737–42.PubMedGoogle Scholar
  70. 70.
    Casale T, Bernstein I, Busse W, et al. Use of an anti-IgE humanized antibody in ragweed induced allergic rhinitis. J Allergy Clin Immunol. 1997;100:110–21.CrossRefPubMedGoogle Scholar
  71. 71.
    Wilson FMII. Adverse external ocular effects of topical ophthalmic medications. Surv Ophthalmol. 1979;24:57–88.CrossRefPubMedGoogle Scholar
  72. 72.
    Woods AC. The diagnosis and treatment of ocular allergy. Am J Ophthalmol. 1949;32:1457–78.CrossRefPubMedGoogle Scholar
  73. 73.
    Srinivasan BD, Jacobiec FA, Iwamoto T, et al. Giant papillary conjunctivitis with ocular prosthesis. Arch Ophthalmol. 1979;97:892–5.CrossRefPubMedGoogle Scholar
  74. 74.
    Binder PS. The physiologic effects of extended wear soft contact lenses. Ophthalmology. 1980;87:745–9.CrossRefPubMedGoogle Scholar
  75. 75.
    Meisler DM, Zaret CR, Stock EL. Trantas’ dots and limbal inflammation associated with soft contact lens wear. Am J Ophthalmol. 1980;89:66–9.CrossRefPubMedGoogle Scholar
  76. 76.
    Fowler SA, Allansmith MR. Evolution of soft contact lens coatings. Arch Ophthalmol. 1980;98:95–9.CrossRefPubMedGoogle Scholar
  77. 77.
    Bowden IIIFW, Cohen EJ. Corneal ulcerations with contact lenses. Ophthalmol Clin N Am. 1998;2:267–73.Google Scholar
  78. 78.
    O’Brien TP, Maguire MG, Fink NE, et al. Efficacy of ofloxacin vs cefazolin and tobramycin in the therapy for bacterial keratitis: report from the bacterial keratitis study research group. Arch Ophthalmol. 1995;113:1257–65.CrossRefPubMedGoogle Scholar
  79. 79.
    McLeod SD, Kolahdouz-Isfahani A, Rostamian K, et al. The role of routine smears, cultures and antibiotic sensitivity testing in the management of suspected infectious keratitis. Ophthalmology. 1996;103:23–8.CrossRefPubMedGoogle Scholar
  80. 80.
    Benson WH, Lanier JD. Comparison of techniques for culturing corneal ulcers. Ophthalmology. 1992;99:800–4.CrossRefPubMedGoogle Scholar
  81. 81.
    Alexandrakis G, Haimovici R, Miller D, Alfonso EC. Corneal biopsy in the management of progressive microbial keratitis. Am J Ophthalmol. 2000;129:571–6.CrossRefPubMedGoogle Scholar
  82. 82.
    Welham RAN, Bergin DJ. Congenital lacrimal fistulas. Arch Ophthalmol. 1985;103:545–8.CrossRefPubMedGoogle Scholar
  83. 83.
    Becker BB, Berry FD. Balloon catheter dilatation and lacrimal surgery. Ophthalmic Surg. 1989;20:193–200.PubMedGoogle Scholar
  84. 84.
    Ozdal PC, Codere F, Callejo S, et al. Accuracy of the clinical diagnosis of chalazion. Eye. 2004;18:135–8.CrossRefPubMedGoogle Scholar

Copyright information

© Springer Nature Singapore Pte Ltd. 2018

Authors and Affiliations

  1. 1.Department of OphthalmologyUniversity of Mississippi Medical CenterJacksonUSA

Personalised recommendations